Professor Zhangli: Preliminary Data of Clinical Trial of EGFR×HER3 Bispecific Antibody ADC Drug is Encouraging, Precise Treatment of Lung Caner being Furthered Improved
Company Address:1#, Building 1,No.161, Baili Road, Cross-Strait Science and Technology Industrial Development Park, Wenjiang District, Chengdu City Postcode:610041 Tel:028-85183639